Akorn, Inc. (NASDAQ:AKRX) Files An 8-K Other Events
Item 8.01.
|
Other Events.
|
release regarding a potential acquisition of the Company. A copy
of the Companys press release is attached as Exhibit 99.1 hereto,
and incorporated herein by reference.
|
Item 9.01
|
Financial Statements and Exhibits.
|
|
EXHIBIT NO.
|
DESCRIPTION
|
|
|
99.1
|
Press Release dated April 7, 2017.
|
About Akorn, Inc. (NASDAQ:AKRX)
Akorn Inc., together with its subsidiaries, is a specialty pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals, as well as private-label over-the-counter (OTC) consumer health products and animal health pharmaceuticals. The Company operates through two segments: Prescription Pharmaceuticals and the Consumer Health. The Prescription Pharmaceuticals segment is engaged in manufacturing and marketing generic and branded prescription pharmaceuticals, including ophthalmics, injectables, oral liquids, otics, topical, inhalants and nasal sprays. The Consumer Health segment is engaged in manufacturing and marketing branded and private-label animal health and OTC products. The Company’s Akorn Consumer Health division (ACH) markets a portfolio of OTC brands and various formulations of private-label OTC pharmaceutical products. Its OTC brand is TheraTears Therapy for Your Eyes, which is a family of therapeutic eye care products. Akorn, Inc. (NASDAQ:AKRX) Recent Trading Information
Akorn, Inc. (NASDAQ:AKRX) closed its last trading session up +4.55 at 29.77 with 24,388,711 shares trading hands.
